Literature DB >> 23482608

Acromegaly has a negative influence on trabecular bone, but not on cortical bone, as assessed by high-resolution peripheral quantitative computed tomography.

Miguel Madeira1, Leonardo Vieira Neto, Francisco de Paula Paranhos Neto, Inayá Corrêa Barbosa Lima, Laura Maria Carvalho de Mendonça, Mônica Roberto Gadelha, Maria Lucia Fleiuss de Farias.   

Abstract

INTRODUCTION: Acromegaly is one of the causes of secondary osteoporosis, although studies of bone mineral density (BMD) have yielded conflicting results and none of them have evaluated the bone properties. OBJECTIVES AND PATIENTS: Our objective was to correlate, in a cohort of 82 acromegalic patients, BMD and bone microarchitecture, using dual-energy x-ray absorptiometry and high-resolution peripheral quantitative computed tomography, with the presence of type 2 diabetes mellitus (T2DM), disease activity, and gonadal status and to compare these bone parameters between 45 eugonadal acromegalic patients and 45 healthy controls.
RESULTS: Acromegalic patients with T2DM had lower trabecular density and trabecular bone volume to tissue volume ratio in the distal tibia. Patients with active acromegaly exhibited a higher BMD and T-score in the lumbar spine (P = .02 for both) and a higher cortical density in the distal tibia when compared with those with controlled acromegaly (P = .001). After multiple linear regression (including age, presence of T2DM, acromegaly activity, and gonadal status), eugonadism remained the main determinant of bone parameters. The 45 acromegalic patients with eugonadism were compared with 45 age- and sex-matched controls and exhibited lower trabecular densities and impaired microstructures.
CONCLUSIONS: Acromegaly appears to have a deleterious effect on trabecular bone microarchitecture, and in this specific population, the gonadal status might be more important than T2DM or acromegaly activity in determining bone health. High-resolution peripheral quantitative computed tomography seems promising for evaluating acromegalic bone properties and for addressing the limitations posed by dual-energy x-ray absorptiometry.

Entities:  

Mesh:

Year:  2013        PMID: 23482608     DOI: 10.1210/jc.2012-4073

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  25 in total

1.  The acromegalic spine: fractures, deformities and spinopelvic balance.

Authors:  Bruno de Azevedo Oliveira; Bruna Araujo; Tainá Mafalda Dos Santos; Bárbara Roberta Ongaratti; Carolina Garcia Soares Leães Rech; Nelson Pires Ferreira; Júlia Fernanda Semmelmann Pereira-Lima; Miriam da Costa Oliveira
Journal:  Pituitary       Date:  2019-12       Impact factor: 4.107

2.  Understanding and predicting fracture risk in acromegaly.

Authors:  Natasha M Appelman-Dijkstra; Nienke R Biermasz
Journal:  Endocrine       Date:  2017-02-02       Impact factor: 3.633

3.  Epicardial fat is a negative predictor of spine volumetric bone mineral density and trabecular bone score in acromegaly.

Authors:  Elena Valassi; Iris Crespo; Jorge Malouf; David Vilades; Ruben Leta; Jaume Llauger; Eulàlia Urgell; Anna Aulinas; Ana Maria Marín; Betina Biagetti; Susan M Webb
Journal:  Endocrine       Date:  2016-04-07       Impact factor: 3.633

Review 4.  Acromegalic osteopathy.

Authors:  G Mazziotti; F Maffezzoni; S Frara; A Giustina
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107

5.  Compromised bone microarchitecture and estimated bone strength in young adults with cystic fibrosis.

Authors:  Melissa S Putman; Carly E Milliren; Nicholas Derrico; Ahmet Uluer; Leonard Sicilian; Allen Lapey; Gregory Sawicki; Catherine M Gordon; Mary L Bouxsein; Joel S Finkelstein
Journal:  J Clin Endocrinol Metab       Date:  2014-06-13       Impact factor: 5.958

6.  Exon 3-deleted growth hormone receptor isoform is not related to worse bone mineral density or microarchitecture or to increased fracture risk in acromegaly.

Authors:  J Pontes; M Madeira; C H A Lima; L L Ogino; F de Paula Paranhos Neto; L M C de Mendonça; M L F Farias; L Kasuki; M R Gadelha
Journal:  J Endocrinol Invest       Date:  2019-08-07       Impact factor: 4.256

7.  Bone histomorphometry in acromegaly patients with fragility vertebral fractures.

Authors:  L Dalle Carbonare; V Micheletti; E Cosaro; M T Valenti; M Mottes; G Francia; M V Davì
Journal:  Pituitary       Date:  2018-02       Impact factor: 4.107

8.  Effects of pegvisomant and somatostatin receptor ligands on incidence of vertebral fractures in patients with acromegaly.

Authors:  Sabrina Chiloiro; Gherardo Mazziotti; Antonella Giampietro; Antonio Bianchi; Stefano Frara; Marilda Mormando; Alfredo Pontecorvi; Andrea Giustina; Laura De Marinis
Journal:  Pituitary       Date:  2018-06       Impact factor: 4.107

9.  Excessive growth hormone expression in male GH transgenic mice adversely alters bone architecture and mechanical strength.

Authors:  S V Lim; M Marenzana; M Hopkinson; E O List; J J Kopchick; M Pereira; B Javaheri; J P Roux; P Chavassieux; M Korbonits; C Chenu
Journal:  Endocrinology       Date:  2015-02-03       Impact factor: 4.736

10.  High-resolution-cone beam tomography analysis of bone microarchitecture in patients with acromegaly and radiological vertebral fractures.

Authors:  Filippo Maffezzoni; Michele Maddalo; Stefano Frara; Monica Mezzone; Ivan Zorza; Fabio Baruffaldi; Francesco Doglietto; Gherardo Mazziotti; Roberto Maroldi; Andrea Giustina
Journal:  Endocrine       Date:  2016-09-06       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.